PHARMACOKINETICS OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN PATIENTS WITH ACUTE-LEUKEMIA

被引：0
|
作者：
UEDA, T
NAKAMURA, T
ANDO, S
KAGAWA, D
SASADA, M
UCHINO, H
JOHNO, I
AKIYAMA, Y
机构：
[1] KYOTO UNIV,FAC MED,DEPT PHARM,KYOTO 606,JAPAN
[2] KYOTO UNIV,FAC MED,DEPT PEDIAT,KYOTO 606,JAPAN
[3] FUKUI MED SCH,DEPT MED,MATSUOKA,FUKUI 91011,JAPAN
来源：
CANCER RESEARCH | 1983年 / 43卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3412 / 3416
页数：5
相关论文
共 50 条
  • [1] PLASMA AND LEUKEMIC-CELL PHARMACOKINETICS OF HIGH-DOSE N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN ACUTE-LEUKEMIA PATIENTS
    YOSHIDA, T
    KOBAYASHI, K
    OKABE, Y
    OKUMURA, H
    MATANO, S
    KANNO, M
    TAKEDA, Y
    OHTAKE, S
    NAKAMURA, S
    MATUDA, T
    JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 34 (01): : 52 - 59
  • [2] TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN ADULTS WITH N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE
    KIMURA, K
    OHNO, R
    AMAKI, I
    HATTORI, K
    HIROTA, Y
    HOSHINO, A
    ICHIMARU, M
    ITO, M
    KIMURA, I
    MAEKAWA, T
    MASAOKA, T
    NAKAMURA, T
    OGAWA, M
    OGURO, M
    OHTA, K
    OSAMURA, S
    SHIMOYAMA, M
    TAKAKU, F
    UZUKA, Y
    YAMADA, K
    CANCER, 1985, 56 (08) : 1913 - 1917
  • [3] CLINICAL USE OF INTERMEDIATE TO HIGH-DOSE OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN CHILDREN WITH ACUTE-LEUKEMIA
    TAKASHIMA, Y
    JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 28 (04): : 356 - 362
  • [4] PHASE-III STUDY OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN ADULT ACUTE-LEUKEMIA -BH-AC-DMP THERAPY
    YAMADA, K
    SUZUKI, H
    KATO, Y
    ACTA HAEMATOLOGICA JAPONICA, 1980, 43 (06): : 1080 - 1085
  • [5] PHASE I-II STUDY OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE
    KIMURA, K
    YAMADA, K
    UZUKA, Y
    MAEKAWA, T
    TAKAKU, F
    SHIMOYAMA, M
    OGAWA, M
    AMAKI, I
    OSAMURA, S
    ITO, M
    SAKAI, Y
    OGURO, M
    HATTORI, K
    HOSHINO, A
    HIROTA, Y
    OHTA, K
    NAKAMURA, T
    MASAOKA, T
    KIMURA, I
    ICHIMARU, M
    RECENT RESULTS IN CANCER RESEARCH, 1981, 76 : 232 - 240
  • [6] PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE
    KIMURA, K
    OHNO, R
    AMAKI, I
    HATTORI, K
    HIROTA, Y
    HOSHINO, A
    ICHIMARU, M
    ITO, M
    KIMURA, I
    MAEKAWA, T
    MASAOKA, T
    NAKAMURA, T
    OGAWA, M
    OGURO, M
    OHTA, K
    OSAMURA, S
    SHIMOYAMA, M
    TAKAKU, F
    UZUKA, Y
    YAMADA, K
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1986, 3 (01): : 15 - 24
  • [7] PRODUCTION OF N-4-SUCCINYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE, A NOVEL METABOLITE OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE, IN MICE AND ITS BIOLOGICAL SIGNIFICANCE
    OHISHI, J
    KATAOKA, T
    TSUKAGOSHI, S
    SAKURAI, Y
    SHIBUKAWA, M
    KOBAYASHI, H
    CANCER RESEARCH, 1981, 41 (06) : 2501 - 2506
  • [8] CYTO-TOXICITY OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE THROUGH GRADUAL CONVERSION TO 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN HELA-CELLS
    MAEHARA, Y
    KUSUMOTO, T
    SAKAGUCHI, Y
    KUSUMOTO, H
    ANAI, H
    SUGIMACHI, K
    ANTICANCER RESEARCH, 1989, 9 (01) : 41 - 44
  • [9] A pilot study of combination chemotherapy with N-4-behenoyl-1-beta-D-arabinofuranosylcytosine, aclacinomycin A and prednisolone (BAP therapy) for refractory adult acute myelogenous leukemia
    Dobashi, N
    Usui, N
    Yamazaki, H
    Nakamura, T
    Kobayashi, T
    Asai, O
    Kuraishi, Y
    BLOOD, 1995, 86 (10) : 3010 - 3010
  • [10] TREATMENT OF JUVENILE CHRONIC MYELOCYTIC-LEUKEMIA WITH MULTIDRUG CHEMOTHERAPY INCLUDING ACLACINOMYCIN AND N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE
    ISHII, E
    MATSUZAKI, A
    KATO, Y
    MIYAZAKI, S
    UEDA, K
    ACTA HAEMATOLOGICA JAPONICA, 1986, 49 (06): : 1297 - 1299
12345